Showing results (121-130 of 132) with videos related to
Sort By:
Pageof 14
Pharmaceutics|January 21, 2022
Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple TargetsPei-Chen Yu, Chen-Hao Huang, Chih-Jung Kuo, et al.Proceedings of the National Academy of Sciences of the United States of America|May 31, 2007
Bisphosphonates target multiple sites in both cis- and trans-prenyltransferasesRey-Ting Guo, Rong Cao, Po-Huang Liang, et al.The Journal of Biological Chemistry|January 16, 2009
Structural basis of inhibition specificities of 3C and 3C-like proteases by zinc-coordinating and peptidomimetic compoundsCheng-Chung Lee, Chih-Jung Kuo, Tzu-Ping Ko, et al.Journal of Medicinal Chemistry|September 20, 2008
Inhibition of geranylgeranyl diphosphate synthase by bisphosphonates: a crystallographic and computational investigationCammy K-M Chen, Michael P Hudock, Yonghui Zhang, et al.Journal of the American Chemical Society|January 31, 2014
Structure and inhibition of tuberculosinol synthase and decaprenyl diphosphate synthase from Mycobacterium tuberculosisHsiu-Chien Chan, Xinxin Feng, Tzu-Ping Ko, et al.Journal of Medicinal Chemistry|August 1, 2007
Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirusChih-Chun Wen, Yueh-Hsiung Kuo, Jia-Tsrong Jan, et al.The Journal of Clinical Investigation|August 28, 2013
Targeting the XIAP/caspase-7 complex selectively kills caspase-3-deficient malignanciesYuan-Feng Lin, Tsung-Ching Lai, Chih-Kang Chang, et al.Proceedings of the National Academy of Sciences of the United States of America|July 1, 2004
Small molecules targeting severe acute respiratory syndrome human coronavirusChung-Yi Wu, Jia-Tsrong Jan, Shiou-Hwa Ma, et al.Antiviral Research|October 20, 2023
Synthesis, evaluation, and mechanism of 1-(4-(arylethylenylcarbonyl)phenyl)-4-carboxy-2-pyrrolidinones as potent reversible SARS-CoV-2 entry inhibitorsSrinivasa Rao Palla, Chen-Wei Li, Tai-Ling Chao, et al.Antimicrobial Agents and Chemotherapy|March 6, 2024
BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivirWen-Fang Tang, Yu-Hsiu Chang, Cheng-Chin Lin, et al.Pageof 14